| 1 |
Awareness and opinions of research professionals about Indiaæs new drugs and clinical trials regulations: Protocol for a cross-sectional online survey (Preprint) |
|
|
| Vishal Vennu,Saurabh Dahiya |
|
| JMIR Research Protocols. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Clinical Trial Regulations in India: Progress and Challenges Arising from Recent Amendments to Schedule Y of the Drugs and Cosmetics (D&C) Act 1940 (D&C Rules 1945) |
|
|
| Amit Kondal,G. V. Murali Krishna,Dipika Bansal |
|
| Pharmaceutical Medicine. 2016; 30(1): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Solving clinical trial delays: innovative solutions |
|
|
| Kavita Singh,M Abdul Salam,Raji Devarajan,Dorairaj Prabhakaran |
|
| Clinical Investigation. 2015; 5(9): 745 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Compensation for Clinical Trial-Related Injury and Death in India: Challenges and the Way Forward |
|
|
| Yogendra Kumar Gupta,Arun Kumar Pradhan,Aman Goyal,Prafull Mohan |
|
| Drug Safety. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Recent Changes to Clinical Trial Regulation in India: Focus on Serious Adverse Events, Compensation and Registration of Ethics Committees |
|
|
| Manoj Karwa,Saurabh Arora,Shilpa Garg Agrawal |
|
| Pharmaceutical Medicine. 2013; 27(5): 283 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
PARTAKE Survey of Public Knowledge and Perceptions of Clinical Research in India |
|
|
| Tal Burt,Savita Dhillon,Pooja Sharma,Danish Khan,Deepa MV,Sazid Alam,Sarika Jain,Bhavana Alapati,Sanjay Mittal,Padam Singh,David Joseph Diemert |
|
| PLoS ONE. 2013; 8(7): e68666 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Um enfoque mais amplo para o Jornalismo Científico |
|
|
| Carlos Henrique Fioravanti |
|
| Intercom: Revista Brasileira de Ciências da Comunicação. 2013; 36(2): 315 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
